IonQ, Inc.

🇺🇸New York Stock Exchange
Back to all articles
IonQ, Inc. stock analysis IONQ overview
Somewhat Bullish +45

Corient Private Wealth LLC Has $2.76 Million Stock Holdings in IonQ ...

📈 Corient Private Wealth LLC increased its IonQ stake by 29.5% in Q4, holding 61,437 shares worth $2.76 million.

📊 Ameriflex Group Inc. boosted its position by 485.7% in Q3, while Fortitude Family Office LLC raised holdings by 3,800% in Q4.

💰 IonQ reported Q1 revenue of $64.67 million, beating estimates of $49.75 million and growing 754.7% year-over-year.

📉 The company posted an EPS miss of ($0.34) versus the expected ($0.26), resulting in a negative return on equity of -23.20%.

🏢 Institutional investors and hedge funds collectively own 41.42% of IonQ's total outstanding stock.

💸 Insider selling activity totaled $701,489 in the last three months, led by John W. Raymond and Director Gabrielle B. Toledano.

🎯 Analyst consensus rating is 'Moderate Buy' with an average price target of $69.88 based on MarketBeat data.

📈 Northland Securities upgraded its price objective to $70.00 with an 'outperform' rating in a June 22nd research note.

🔬 IonQ provides access to quantum computing systems via cloud platforms including AWS, Azure Quantum, and Google Cloud Marketplace.

⚖️ Ten analysts rate the stock as Buy, six as Hold, and one as Sell according to recent data aggregators.

Bullish Signals
  • IonQ generated $64.67 million in revenue for the quarter, significantly beating the consensus estimate of $49.75 million.
  • Revenue grew by 754.7% compared to the same quarter last year, demonstrating rapid top-line expansion.
  • Corient Private Wealth LLC increased its investment position by 29.5% in Q4, signaling strong institutional confidence.
  • Ameriflex Group Inc. and Fortitude Family Office LLC made substantial percentage increases in their holdings during recent quarters.
  • Institutional ownership stands at 41.42%, indicating significant backing from major hedge funds and wealth management firms.
  • Northland Securities raised its price target to $70.00 and assigned an 'outperform' rating, reflecting bullish analyst sentiment.
  • The company maintains a net margin of 174.88%, highlighting high profitability relative to its current revenue base.
Risk Factors
  • IonQ reported an EPS of ($0.34), missing analyst consensus estimates of ($0.26) by $0.08.
  • The company recorded a negative return on equity of -23.20%, indicating financial leverage or early-stage losses relative to shareholder equity.
  • Insiders sold a total of 13,102 shares valued at $701,489 in the last three months, including significant sales by John W. Raymond and Director Gabrielle B. Toledano.
  • Wall Street Zen downgraded IonQ from 'strong sell' to 'sell', while Weiss Ratings upgraded it only marginally from 'sell (d-)' to 'sell (d+)'.
Full Analysis
Corient Private Wealth LLC significantly increased its position in IonQ, Inc. (NYSE:IONQ) by 29.5% in the fourth quarter, acquiring an additional 13,996 shares to hold a total of 61,437 shares valued at $2.76 million. Several other institutional investors, including Ameriflex Group Inc., Beaird Harris Wealth Management LLC, and Accent Capital Management LLC, also boosted their stakes during the third and fourth quarters, while Fortitude Family Office LLC raised its holdings by a substantial 3,800%. Collectively, these institutional and hedge fund investors now own 41.42% of the company's outstanding stock. IonQ reported quarterly earnings on May 6th that exceeded revenue expectations, posting $64.67 million in revenue compared to the consensus estimate of $49.75 million, representing a year-over-year increase of 754.7%. Despite the strong top-line growth, the company reported an EPS of ($0.34), which missed analyst estimates of ($0.26). The business achieved a net margin of 174.88% but maintained a negative return on equity of -23.20%, reflecting its early-stage operational profile. Recent insider activity shows mixed signals, with John W. Raymond selling 3,815 shares and Director Gabrielle B. Toledano selling 2,757 shares in late June, totaling $701,489 in insider sales over the last three months. Analyst sentiment remains cautiously optimistic with a consensus rating of 'Moderate Buy' and an average price target of $69.88, though recent upgrades from Wall Street Zen and Weiss Ratings suggest a gradual shift from strong sell to sell or outperform ratings.